Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future

Author:

Baldanti Fausto1,Ganguly Nirmal K.2,Wang Guiqiang3,Möckel Martin4,O’Neill Luke A.5,Renz Harald67,dos Santos Ferreira Carlos Eduardo8,Tateda Kazuhiro9,Van Der Pol Barbara10ORCID

Affiliation:

1. Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

2. Indian Council of Medical Research, New Delhi, India

3. The Center for Liver Diseases, Peking University First Hospital, Beijing, China

4. Charité – Universitätsmedizin, Berlin, Germany

5. Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

6. Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, University Hospital Giessen and Marburg GmbH, Giessen, Germany

7. Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

8. Albert Einstein Hospital, São Paulo, Brazil

9. Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan

10. Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA

Funder

Roche Diagnostics

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,General Biochemistry, Genetics and Molecular Biology

Reference142 articles.

1. FIND. COVID-19 pipeline; 2021 [cited 2021 Nov 30]. Available from: https://www.finddx.org/covid-19/pipeline/

2. European Centre for Disease Prevention and Control. Testing strategies for SARS-CoV-2; 2021 [cited 2021 Nov 30]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/testing-strategies

3. WHO. Diagnostic testing for SARS-CoV-2; 2020 [cited 2021 Nov 30]. Available from: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2

4. Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance

5. SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3